In the 2021 Korea Future Management Award, NKCL Bio Group
won the Grand Prize in Auspicious Bio Firm category, as hosted by Herald
Economy and Korea Herald, and sponsored by Monthly Power Korea. This is their
second consecutive win in the category, following last year’s win.
NKCL Bio Group uses an NK cell GMP automated cultivation
system to provide personalized immunity care platform that corresponds to
customers’ status and requests. In addition, they use microbiome technology to
launch tech and products closely related to the daily life, introducing immune
lifestyle and functional medicine solutions to customers.
On January 22, NKCL founded the Microbiome lab, where they
use microbiome research data to make health supplements, cosmetics, and other
food products to help customers improve immunity. They are also planning to
build an NKCL intestinal microorganism inspection center. The advanced research
technology and system of the U.S. will be introduced.